Laboratorios Farmaceuticos ROVI (ROVI.MC)
Company Info
Highlights
€3.34B
€3.18
20.55
€563.97M
€334.55M
€143.29M
€49.44 - €93.81
€68.09
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Laboratorios Farmaceuticos ROVI, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Laboratorios Farmaceuticos ROVI had a return of 4.41% year-to-date (YTD) and 21.58% in the last 12 months. Over the past 10 years, Laboratorios Farmaceuticos ROVI had an annualized return of 22.26%, outperforming the S&P 500 benchmark which had an annualized return of 11.10%.
ROVI.MC
4.41%
-18.27%
-28.41%
21.58%
21.34%
22.26%
^GSPC (Benchmark)
23.56%
0.49%
11.03%
30.56%
13.70%
11.10%
Monthly Returns
The table below presents the monthly returns of ROVI.MC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 6.40% | 15.61% | 9.25% | 4.20% | 4.09% | -0.23% | 2.73% | -10.62% | -9.99% | 9.08% | 4.41% | ||
| 2023 | 7.65% | 7.42% | -7.72% | 4.42% | 2.84% | 2.47% | 5.73% | 20.25% | -2.19% | -1.75% | 11.30% | 7.21% | 71.18% |
| 2022 | -11.38% | 10.55% | -7.05% | -2.98% | -4.29% | -6.41% | -11.48% | -3.80% | -9.91% | 4.12% | -20.86% | -0.99% | -50.47% |
| 2021 | 7.12% | 11.33% | 1.77% | 4.78% | 18.26% | 2.46% | 2.42% | -10.92% | 6.60% | 7.26% | 6.60% | 14.24% | 95.75% |
| 2020 | 2.05% | -2.01% | -6.97% | 14.10% | -10.81% | 9.52% | 14.62% | -3.10% | 11.74% | -2.55% | 32.83% | -6.42% | 55.89% |
| 2019 | 6.02% | -0.54% | 1.90% | -1.87% | 5.16% | 3.88% | 4.32% | 8.13% | -3.10% | 0.91% | 8.15% | 2.09% | 40.28% |
| 2018 | 2.88% | 4.04% | 1.49% | -0.88% | -6.53% | -0.32% | 3.52% | 1.86% | -3.95% | 3.16% | 7.06% | -0.00% | 12.21% |
| 2017 | 7.22% | 2.12% | 8.52% | 3.62% | 2.11% | 10.13% | -4.74% | 0.93% | -0.49% | -0.49% | 1.99% | -4.75% | 28.04% |
| 2016 | -3.05% | -7.64% | 14.23% | -0.00% | -1.83% | -3.46% | -6.99% | 4.88% | -4.36% | -5.02% | -4.39% | 4.85% | -13.89% |
| 2015 | 5.73% | 30.39% | 14.93% | -6.31% | 1.70% | -9.90% | -0.55% | -7.46% | 3.92% | 3.09% | 5.56% | -0.00% | 41.54% |
| 2014 | -1.80% | 1.43% | -1.91% | 1.23% | 0.41% | -4.24% | 2.55% | -3.23% | -8.50% | 0.59% | 7.02% | 12.57% | 4.62% |
| 2013 | 9.62% | 8.43% | 9.68% | 0.43% | -1.30% | 1.61% | 9.45% | 2.13% | 4.18% | 11.28% | 11.94% | 0.40% | 91.25% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ROVI.MC is 60, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Laboratorios Farmaceuticos ROVI (ROVI.MC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Laboratorios Farmaceuticos ROVI provided a 1.44% dividend yield over the last twelve months, with an annual payout of €0.89 per share. The company has been increasing its dividends for 4 consecutive years.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | €0.89 | €1.05 | €0.77 | €0.31 | €0.14 | €0.06 | €0.10 | €0.15 | €0.11 | €0.14 | €0.13 | €0.11 |
Dividend yield | 1.44% | 1.74% | 2.15% | 0.42% | 0.37% | 0.26% | 0.56% | 0.95% | 0.91% | 0.94% | 1.24% | 1.08% |
Monthly Dividends
The table displays the monthly dividend distributions for Laboratorios Farmaceuticos ROVI. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.89 | €0.00 | €0.00 | €0.00 | €0.00 | €0.89 | |
| 2023 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.05 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.05 |
| 2022 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.77 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.77 |
| 2021 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.31 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.31 |
| 2020 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.14 | €0.00 | €0.14 |
| 2019 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.06 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.06 |
| 2018 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.10 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.10 |
| 2017 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.15 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.15 |
| 2016 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.11 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.11 |
| 2015 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.14 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.14 |
| 2014 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.13 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.13 |
| 2013 | €0.11 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.11 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Laboratorios Farmaceuticos ROVI. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Laboratorios Farmaceuticos ROVI was 66.94%, occurring on Mar 6, 2009. Recovery took 1497 trading sessions.
The current Laboratorios Farmaceuticos ROVI drawdown is 31.30%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -66.94% | Feb 26, 2008 | 261 | Mar 6, 2009 | 1497 | Jan 15, 2015 | 1758 |
| -51.02% | Jan 3, 2022 | 255 | Dec 28, 2022 | 295 | Feb 22, 2024 | 550 |
| -31.96% | Apr 8, 2015 | 418 | Nov 18, 2016 | 137 | Jun 5, 2017 | 555 |
| -31.36% | May 27, 2024 | 125 | Nov 15, 2024 | — | — | — |
| -25.48% | Aug 24, 2021 | 5 | Aug 30, 2021 | 79 | Dec 17, 2021 | 84 |
Volatility
Volatility Chart
The current Laboratorios Farmaceuticos ROVI volatility is 16.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Laboratorios Farmaceuticos ROVI.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |